A more appropriate diagnosis for this situation is focal necrosis (see the following)
For most adults, stretch marks are a basic fact of life whether we like it or not
McLaughlin breaks down who may qualify for GLP-1 therapy You may be a candidate if you have: BMI 30 (obesity), or BMI 27 with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, sleep apnea) Type 2 diabetes or prediabetes Insulin resistance or metabolic syndrome Cardiovascular risk factors where weight loss would improve outcomes GLP-1s are typically not approved for patients with: Personal or family history of medullary thyroid cancer or MEN2 Prior severe pancreatitis linked to GLP-1 use Significant untreated GI disorders or eating disorders Approval may also depend on insurance requirements, documented lifestyle attempts, and whether the prescription is for diabetes vs
And there are other ways to make the drug, likely somewhat more expensive or harder to scale, at least for now, as a look at the patent literature will show you
Retatrutide has shown the highest weight loss numbers in trials so far (28.7% in Phase 3 TRIUMPH-4 vs 22.5% for tirzepatide in SURMOUNT-1 and 15.8% for semaglutide in STEP-1)
